115 related articles for article (PubMed ID: 38411267)
1. TMED3 stabilizes SMAD2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
[TBL] [Abstract][Full Text] [Related]
2. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR.
Xie A; Xu X; Kuang P; Zhang L; Yu F
Cell Death Dis; 2021 Aug; 12(9):804. PubMed ID: 34429402
[TBL] [Abstract][Full Text] [Related]
3. TMED3/RPS15A Axis promotes the development and progression of osteosarcoma.
Xu W; Li Y; Ye X; Ji Y; Chen Y; Zhang X; Li Z
Cancer Cell Int; 2021 Nov; 21(1):630. PubMed ID: 34838013
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells.
Yang J; Huang H; Xiao D; Duan Y; Zheng Y; Chen Z
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760171
[TBL] [Abstract][Full Text] [Related]
5. TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway.
Guo X; Yin X; Xu Y; Li L; Yuan M; Zhao H; Jiang Y; Shi X; Bi H; Liu Y; Chen Y; Xu Q
Cell Biosci; 2023 Mar; 13(1):65. PubMed ID: 36991473
[TBL] [Abstract][Full Text] [Related]
6. TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT.
Zhang D; Sun L; Zhang J
Toxicol Appl Pharmacol; 2021 Dec; 433():115793. PubMed ID: 34758370
[TBL] [Abstract][Full Text] [Related]
7. Trafficking protein TMED3 promotes esophageal squamous cell carcinoma.
Yang Y; Liu S; Xie C; Li Q; Gao T; Liu M; Xi M; Zhao L
Biomed J; 2023 Apr; 46(2):100528. PubMed ID: 35358714
[TBL] [Abstract][Full Text] [Related]
8. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma.
Liao G; Zhang M; Wang C
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3485-3494. PubMed ID: 35951089
[TBL] [Abstract][Full Text] [Related]
9. Depleting TMED3 alleviates the development of endometrial carcinoma.
Zhang J; Qi Y
Cancer Cell Int; 2022 Jul; 22(1):231. PubMed ID: 35854294
[TBL] [Abstract][Full Text] [Related]
10. The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.
Mishra S; Bernal C; Silvano M; Anand S; Ruiz I Altaba A
Oncogene; 2019 Jul; 38(29):5817-5837. PubMed ID: 31253868
[TBL] [Abstract][Full Text] [Related]
11. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
Li D; Wang M
Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
[TBL] [Abstract][Full Text] [Related]
12. TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.
Pei J; Zhang J; Yang X; Wu Z; Sun C; Wang Z; Wang B
Cancer Cell Int; 2019; 19():75. PubMed ID: 30976199
[TBL] [Abstract][Full Text] [Related]
13. TMED3 Promotes Proliferation and Migration in Breast Cancer Cells by Activating Wnt/β-Catenin Signaling.
Zhang X; Luo Y; Li Q
Onco Targets Ther; 2020; 13():5819-5830. PubMed ID: 32606792
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling.
Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J
RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584
[TBL] [Abstract][Full Text] [Related]
15. TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling.
Zheng H; Yang Y; Han J; Jiang WH; Chen C; Wang MC; Gao R; Li S; Tian T; Wang J; Ma LJ; Ren H; Zhou WP
Sci Rep; 2016 Nov; 6():37070. PubMed ID: 27901021
[TBL] [Abstract][Full Text] [Related]
16. Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA MALAT1 and Autophagy-Related Protein ATG7 Promotes Autophagy and Invasion in Ovarian Cancer.
Hu J; Zhang L; Mei Z; Jiang Y; Yi Y; Liu L; Meng Y; Zhou L; Zeng J; Wu H; Jiang X
Cell Physiol Biochem; 2018; 47(2):654-666. PubMed ID: 29794480
[TBL] [Abstract][Full Text] [Related]
17. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
18. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
[TBL] [Abstract][Full Text] [Related]
19. Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis.
Yang C; Wang M; Huang R; Ou L; Li M; Wu W; Lei R
Clin Breast Cancer; 2023 Apr; 23(3):291-301. PubMed ID: 36764873
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of
Ha M; Moon H; Choi D; Kang W; Kim JH; Lee KJ; Park D; Kang CD; Oh SO; Han ME; Kim YH; Lee D
Front Genet; 2019; 10():355. PubMed ID: 31057605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
